Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders - Quiz - MDSpire

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders

  • By

  • Eilidh M Duncan

  • Jhulia Salviano

  • Charalampia Kyriakou

  • Samantha Nier

  • Simone Oerlemans

  • Sam Salek

  • Kate Morgan

  • Katie Joyner

  • May 4, 2026

  • 0 min

Share

Original Source(s)

Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders

  • by Eilidh M Duncan, Jhulia Salviano, Charalampia Kyriakou, Samantha Nier, Simone Oerlemans, Sam Salek, Kate Morgan, Katie Joyner

  • May 4, 2026

Related Content

Assessment of the Safety and Effectiveness of CD38-Targeted CAR-T Cell Therapy in Treating Multiple Myeloma: A Systematic Review and Meta-Analysis

Opinion: a call for safe therapeutic and gastric interventions for adolescents and young adults with obesity and transplant-indicated leukemia

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma